爱美医疗 FOLD 深 沪
等待开盘 12-29 09:30:00 美东时间
14.25
0.000
0.00%
华盛通- 最 高14.275
- 今 开14.23
- 成交量 518.12万股
- 最 低 14.23
- 昨 收 14.25
- 总市值 44.03亿
- 52周最高 14.36
- 市盈率 静 --
- 换手率 1.68%
- 52周最低 5.51
- 委 比 60.63%
- 总股本 3.09亿
- 历史最高 25.39
- 量 比 0.10
- 振 幅 0.32%
- 历史最低 1.765
- 每 手 1
- 风险率 1.61%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Leerink Partners Downgrades Amicus Therapeutics to Market Perform, Lowers Price Target to $14.5
Leerink Partners analyst Joseph Schwartz downgrades Amicus Therapeutics (NASDAQ:FOLD) from Outperform to Market Perform and lowers the price target from $17 to $14.5.
2分钟前
Is the Market Bullish or Bearish on Amicus Therapeutics Inc?
Amicus Therapeutics Inc's (NYSE:FOLD) short interest as a percent of float has ...
12-25 04:00
What's Going On With BioMarin Stock On Tuesday?
BioMarin to acquire Amicus for $4.8 billion as analysts see $1 billion peak sales assets, EPS accretion, and stronger long-term rare disease growth.
12-24 02:05
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
12-23 12:32
美股大行评级 | 绩后评级出炉！联邦快递获多家大行上调目标价；耐克遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Pyxis Oncology"买入"评级，目标价从5美元升至7美元；Stifel：维持Oculis Holding"买入"评级，目标价从35美元升至40美元
12-22 15:05
美股牛股 | 太空概念股普涨，LUNR涨近38%；爱美医疗涨超30%，获拜玛林制药48亿美元收购
NovaBay Pharmaceuticals涨79.7%；Lunar Corporation涨37.7%；D-MARKET Electronic Services & Trading涨37.1%
12-20 10:49
美股周涨跌榜 | 特朗普媒体科技集团周涨51.1%，拟并购TAE转型聚变能源公司；Medline周涨43.6%
DJT周涨51.1%，拟并购TAE转型聚变能源公司；Medline周涨43.6%，本周首挂上市，为年内全球最大规模IPO；爱美医疗周涨34.4%，获拜玛林制药48亿美元收购>>
12-20 09:40
Needham Downgrades Amicus Therapeutics to Hold
Needham analyst Gil Blum downgrades Amicus Therapeutics (NASDAQ:FOLD) from Buy to Hold.
12-20 00:17
BioMarin Boosts Rare Disease Portfolio With Amicus Buyout, Stocks Rally
BioMarin acquires Amicus for $4.8B, expanding its rare disease portfolio with Fabry and Pompe therapies, in a deal expected to close Q2 2026.
12-20 00:07
Amicus Therapeutics to Be Acquired by BioMarin
Amicus ( ($FOLD) ) has shared an update. On December 19, 2025, Amicus Therapeut...
12-19 22:46
